drugset / Trial / NCT01799057

The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication

NCT01799057 ↗

Phase 4 Terminated 2 enrolled Baker Heart and Diabetes Institute
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the effects of metformin on functional capacity (pain-free and maximum walking times) in individuals with peripheral artery disease (PAD)-related intermittent claudication.

Timeline

Start
2013-07
Primary completion
2014-12
Completion
2014-12

Outcome

Outcome not reported

Stopped (Enrollment): “The trial has been terminated due to difficulties with recruitment.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg Oral
Subject Metformin Small molecule 1000 mg Oral